南方财经记者 石恩泽 深圳报道 当然，规模化落地的挑战仍然存在，涉及技术的稳定性、场景的复杂性与成本效益的持续优化，都将成 为接下来磨合的关键。 值得一提的是，这不仅是技术与场景的结合，更有着广大的市场空间。据港投公司预测，到2028年，全 球具身智能市场规模预计达138亿美元，医疗健康被列为重点应用方向，若以医疗领域占20%计算，对 应规模将达到约27.6亿美元。双方预期具身智能机器人市场规模将持续大幅增长，医药健康领域将成为 具身智能机器人应用与推广的重要场景。 除了企业与企业之间合作意愿强烈，在政策上，中国正在鼓励具身智能进入医药工业。近日，工业和信 息化部等七部门联合发布实施《医药工业数智化转型实施方案（2025—2030年）》，明确提出医药工业 高质量发展是推进新型工业化和建设制造强国的重要任务，是实施健康中国战略的重要支撑。 值得一提的是，自去年起，已经有互联网巨头尝试引入具身智能在医药零售场景里。2024年9月，在中 国国际服务贸易交易会的美团展位上，美团买药与银河通用联合打造了全球首个人形机器人智慧药房解 决方案，由银河通用机器人Galbot完成24小时无人值守，在美团买药展位不间断地完成着补 ...

Group 1 - The core viewpoint of the news is that 越疆 (02432) has entered into a strategic cooperation agreement with 药师帮股份有限公司 (09885) to explore the integration of robotics and AI in the pharmaceutical industry [1][2] - The collaboration will focus on pharmaceutical collaborative robots, AI large models, and drug IoT technology, aiming to enhance applications in drug research, storage, distribution, retail, and medication services [1] - The first phase of the cooperation will target the deployment of collaborative robots in pharmacies and drug warehouses, with a feasibility study and technical assessments already completed [1] Group 2 - Both parties will adhere to principles of collaborative innovation and mutual development, sharing technical data and newly generated intellectual property and trade secrets [2] - The agreement grants the group exclusive production rights for the robots, while 药师帮 will have exclusive sales rights in the pharmaceutical sector [2] - The board of the group believes that this strategic partnership will facilitate resource integration, collaborative innovation, and promote technological advancement in the industry, ultimately benefiting social health [2]

Investment Rating - The report maintains a "Recommended" rating for the industry, indicating a positive outlook for the sector's fundamentals and expectations for the industry index to outperform the benchmark index [7]. Core Insights - The industry is entering a commercialization phase, particularly in the unmanned logistics sector, driven by the upcoming launch of Tesla's Robotaxi service and supportive policies from the postal authority [5][4]. - The Shanghai Pudong New Area has introduced a comprehensive set of 16 policies to support the development of the embodied intelligence industry, including financial support of up to 20 million yuan for key technology breakthroughs [3]. - The report highlights significant investment opportunities in companies involved in embodied intelligence, particularly those focusing on training models, chips, and robotics [6]. Summary by Sections Industry Events - Tesla plans to launch its Robotaxi service on June 12, marking a significant milestone in the autonomous vehicle and AI space [1]. - Honor has confirmed its entry into the robotics business during its product launch event [2]. - The National Postal Administration has announced initiatives to accelerate technological development in the postal industry, emphasizing AI applications [4]. Market Performance - The industry has shown strong performance, with a 15% absolute return over the past month and a 20.9% return over the past year [9]. - The total market capitalization of the industry stands at 3,839.5 billion yuan, with 475 listed companies [7]. Investment Opportunities - Key investment targets include: - Nvidia (NVDA) for embodied intelligence training and chip solutions [6]. - Tesla (TSLA) and other robotics manufacturers like UBTECH and Yujian for embodied intelligence products [6]. - Companies providing core components such as motor control chips and sensors [11]. Financing Events - Various financing events have been recorded, with companies like Shanjing Harmonic raising significant funds to expand production capacity and enhance automation [13]. - Notable investments include 3 billion yuan for Shanjing Harmonic and undisclosed amounts for other startups focusing on embodied intelligence [14].

Group 1 - The core viewpoint of the articles is that humanoid robots are beginning to enter factories to perform tasks traditionally done by human workers, marking a shift in their application from research and education to industrial settings [1][5][6] - Major companies like Midea and Xiaopeng are actively developing and deploying humanoid robots for various tasks in manufacturing, indicating a growing trend in the industry [1][9] - Humanoid robots are designed to handle a wider range of tasks in diverse industrial environments compared to traditional industrial and collaborative robots, which are typically limited to specific functions [1][4][5] Group 2 - Humanoid robots are expected to complement existing industrial and collaborative robots by performing complex operations that require flexibility and adaptability in non-standardized environments [4][6][10] - The current limitations of humanoid robots include challenges in motion control, material recognition, and battery technology, which need to be addressed for effective industrial application [2][8] - The integration of humanoid robots into factory workflows is seen as a solution to labor shortages in traditional manufacturing roles, particularly in complex assembly tasks [5][9] Group 3 - Companies are exploring the use of humanoid robots in various tasks such as material handling, sorting, and packaging, particularly in automotive manufacturing [4][9] - The collaboration between humanoid robots and traditional robots can enhance operational efficiency, as demonstrated by successful trials in factories [7][9] - The economic feasibility of deploying humanoid robots in factories remains a concern, with current costs ranging from 500,000 to 1,000,000 yuan per unit, necessitating cost reductions for widespread adoption [11]

Group 1 - Technology companies are increasingly heading to the Hong Kong stock market, with 5 companies having passed hearings and 155 in process as of May 29, many seeking to raise over $1 billion [1] - The Hong Kong IPO market has seen 27 companies listed this year, raising a total of HKD 77.12 billion, with notable performances from companies like CATL and Heng Rui Medicine [1] - The acceleration of companies going public in Hong Kong is driven by business expansion needs and supportive policies, enhancing the global positioning of Chinese enterprises [1] Group 2 - The Hong Kong Stock Exchange has introduced tailored listing rules for specialized technology companies, allowing those not meeting standard conditions to list under Chapter 18C [2] - The "Tech Company Fast Track" initiative aims to streamline the listing process for specialized technology and biotech firms, with several companies already submitting applications [2] - As of now, 10 companies have submitted applications under Chapter 18C, indicating a growing interest in the Hong Kong market [2] Group 3 - A-share companies from sectors like semiconductors and renewable energy are planning to optimize financing channels and expand international business through Hong Kong IPOs [3] - Recent regulatory improvements in overseas listing policies are facilitating better access for Chinese tech companies to global capital markets [3] - The introduction of new listing rules is expected to attract more high-quality tech firms to the Hong Kong market, enhancing their global presence [3] Group 4 - The Hong Kong stock market is experiencing improved liquidity and valuation, with a convergence in the AH share premium rate [4] - The AH share premium index has decreased significantly from 151.61 in September 2022 to 131.65 as of May 29, indicating a narrowing price gap between A-shares and H-shares [5] - Net inflows from southbound funds into Hong Kong stocks have reached HKD 641.30 billion this year, significantly surpassing the previous year [5]

Group 1 - The International Robot Skills Competition will be held in Shanghai on May 29, focusing on the theme "Labor is Most Glorious" and aims to promote high-quality development in the Shanghai robotics industry [1] - The competition is expected to activate new momentum for the robotics industry by gathering top experts and companies, focusing on technology implementation and ecosystem construction [1] - The G1 robot demonstrated strong balance and fluid motion in combat competitions, with advancements in motion control models and simulation data training expected to accelerate commercialization [1] Group 2 - The humanoid robot industry has entered its third phase, showing preliminary intelligence and interaction capabilities, with a clear long-term trend of "machines replacing humans" [2] - Tesla's release of the Optimus robot is driving cost reduction and acceleration in the industry, utilizing bionic joint design and hollow cup motor technology, benefiting core component manufacturers [2] Group 3 - DCH Holdings (00179) has strong technical integration capabilities in brushless DC motors and metal processing, entering the humanoid robot industry to unlock new growth opportunities [3] - SUTENG (02498) expects to sell approximately 544,000 laser radars in 2024, a significant increase of 109.6% year-on-year, maintaining a leading market share of 26% globally [3] - YUEJIANG (02432) is a leading collaborative robot company, with plans to release humanoid robot products, benefiting from technological advancements and rising labor costs [3] Group 4 - TSUGAMI (01651) is positioned to benefit from the demand for machine tools in humanoid robot mass production, with an estimated incremental space of 23.543 billion yuan for producing 1 million units [4] - The company has reached an agreement to acquire land for a new production facility to meet the growing demand for high-precision machine tools in the automotive and humanoid robot sectors [4]

海外人形机器人行业 2025 年中期策略 20250527 摘要 人形机器人市场潜力巨大，预计到 2035 年中美两国年产值将达千亿元 级别，工信部视其为继计算机、智能手机、新能源汽车后的颠覆性产品， 预示着长期战略投资价值。 中资公司深度参与人形机器人供应链，尤其在宇树科技链和智元机器人 链中占据主导地位，相较外资企业，中资零部件公司凭借技术突破和产 能释放，增长弹性更被看好，未来业绩有望显著提升。 万得人形机器人指数显示，海外及内地上市的中资公司股价表现优于外 资，反映市场投资风格差异及中资公司潜在业绩弹性，但短期股价波动 受事件、政策及资金面影响较大。 人形机器人产业结构分为整机、大脑、执行器和传感器四大类，中资在 整机和零部件领域与外资旗鼓相当，重点关注越疆优必选等产品企业， 金力永磁、敏实集团等执行器部件企业，以及速腾聚创、禾赛科技等传 感器企业。 股价波动受多重因素影响：技术突破、产品发布及量产进度构成事件驱 动；政策支持对行业发展至关重要；资金因素如换手率和港股通利好消 息均能推动股价上涨。 Q&A 2025 年全球人形机器人行业的量产情况如何？ 2025 年是全球人形机器人行业的量产元年，主要 ...

Core Viewpoint - The collaborative robot sector is experiencing intense competition among key players, with distinct strategic differences and industry challenges emerging as they navigate market dynamics and capital operations [3][19]. Group 1: Company Performance - Aobo has maintained its position as the industry leader with the highest domestic shipment volume for four consecutive years and ranks second globally, achieving over 90% localization of core components [4]. - Yuejiang ranks first among all collaborative robot companies in China and second globally, with a market share of 13% and over 80,000 units shipped worldwide, generating 59% of its revenue from overseas markets [4]. - Jieke has achieved a compound annual growth rate of 41% in revenue from 2021 to 2023, with 2023 revenue slightly surpassing Yuejiang at 350 million yuan, despite a lower market share of approximately 8.2% [5]. Group 2: Financial Highlights - Yuejiang's 2024 financial summary indicates total revenue of 374 million yuan, a year-on-year increase of 30.32%, with a net loss of 95 million yuan, narrowing by 7.67% [7][8]. - Jieke's financial data shows total revenue of approximately 166.79 million yuan for the first half of 2024, with total costs reaching 178.37 million yuan, resulting in a net loss of 32.54 million yuan [6][10]. - Aobo's recent funding rounds have raised concerns about cash flow, with reports of stalled IPO plans and a failed collaboration with China Resources worth 3.6 billion yuan [11]. Group 3: Market Dynamics - The average price of domestic collaborative robots has decreased from 72,000 yuan per unit in 2021 to 48,000 yuan in 2025, leading to an average gross margin below 40% [12]. - Yuejiang's aggressive pricing strategy has resulted in high sales expenses of 200 million yuan in 2024, revealing the unsustainability of its "loss for market share" model [12][13]. - The collaborative robot industry faces challenges such as technology homogenization and low penetration in industrial applications, with emerging fields like healthcare and agriculture still underdeveloped [15]. Group 4: Capital and Regulatory Environment - The number of financing events in the domestic robot industry has declined significantly from 337 in 2021 to 240 in 2023, indicating a retreat of capital investment [18]. - Jieke's IPO attempts have faced scrutiny from regulators due to ongoing losses and aggressive expansion plans, highlighting the cautious approach of the market towards such business models [9][18]. - The competitive landscape among Aobo, Yuejiang, and Jieke reflects broader industry challenges in overcoming foreign monopolies and achieving high-quality development [19].

Market Overview - The US financial market experienced a "triple kill" in stocks, bonds, and currencies, leading to a decline in the Hong Kong stock market, with the Hang Seng Index dropping 1.19% to 23,544.31 points and a total trading volume of HKD 198.23 billion [1] - The Hang Seng Technology Index performed the worst, falling over 2% at one point during the trading day [1] - Huatai Securities noted that rising US Treasury yields near 4.5%, economic pressures in the US, and a lack of trading direction due to tariff expectations could disrupt the Hong Kong market [1] Blue-Chip Stocks Performance - Xiaomi Group-W (01810) saw a decline of 2.3%, closing at HKD 53.2, with a trading volume of HKD 10.735 billion, negatively impacting the Hang Seng Index by 36.31 points [2] - Other blue-chip stocks included Chow Tai Fook (01929) which rose 4.37%, JD Health (06618) up 2.47%, while Alibaba Health (00241) fell 6.42% and Budweiser APAC (01876) dropped 4.13% [2] Sector Highlights - Major technology stocks were mostly down, with Alibaba falling 3.25% and Xiaomi dropping nearly 3% [3] - Bitcoin surpassed USD 110,000, reaching a new historical high, with cryptocurrency ETFs and related stocks becoming active [3][4] - Gold stocks generally performed well due to a weaker dollar and increased risk aversion, with several pharmaceutical and consumer stocks also rising [3] Cryptocurrency Developments - Bitcoin's market capitalization exceeded USD 2.1 trillion, with a significant legislative push for stablecoin regulation in the US [4] - The upcoming Bitcoin 2025 conference in Las Vegas is expected to influence the future of Bitcoin and global digital currency regulation [4] Consumer Sector Insights - The consumer sector showed positive movement, with Miniso (09896) rising 7.91% and other brands like Old Puhuang Gold (06181) and Pop Mart (09992) also seeing gains [4][5] - Open Source Securities highlighted investment opportunities in consumer recovery themes, focusing on jewelry, retail, cosmetics, and medical aesthetics [5] Gold Stocks Performance - Gold stocks exhibited mixed results, with companies like WanGuo Gold Group (03939) and Lingbao Gold (03330) seeing gains, while others like Chifeng Jilong Gold (06693) experienced slight declines [5] - International gold prices fluctuated, with spot gold reaching USD 3,340 per ounce [5] Robotics Sector - Robotics stocks saw an uptick, with companies like Delta Electronics (00179) and Yujian (02432) reporting gains [6] - The upcoming CMG World Robot Competition is expected to boost interest in the robotics sector [6] Notable Stock Movements - InnoCare (02577) surged 14.29% following news of its collaboration with Nvidia on GaN and SiC technologies [7] - XPeng Motors (09868) reported a 141.5% year-on-year revenue increase for Q1 2025, with a gross margin of 15.6% [8] - Weibo (09898) reported stable revenue with a significant net profit increase of 116.36% year-on-year [9] - Tehai International (09658) faced a decline of 10.3% despite reporting a revenue increase of 5.4% for Q1 2025 [10]

截 至 2025 年 5 月 14 日 ， 港 交 所 拟 上 市 公 司 中 显 示 " 聆 讯 通 过"的有2家，显示"处理中"的有150家。 作者：牛钰 封图：图虫创意 前有知名玩具品牌布鲁可（0325.HK）、餐饮界的"雪王"蜜雪集团（2097.HK）在港交所挂牌上 市，后有A股"宁王"宁德时代（300750.SZ）、"药王"恒瑞医药（600276.SH）分别于5月12日、5 月15日启动H股全球公开发售，2025年以来，港股市场迎来一家又一家备受瞩目的行业新贵。 "去香港上市"成了2025年资本圈的热词。 港股正在接纳诸多谋划"A+H"双重上市的A股上市公 司，也迎来了一批消费、医疗、科技等行业的新兴企业。 Wind数据显示，2025年初至5月14日，已经有21家企业登陆港股市场，同比增加6家；合计募资 234.72亿港元，同比增长198.32%。 香港交易所（下称"港交所"）在政策层面也给企业赴港上市热添了一把"新柴"。5月6日，港交所推 出"科企专线"上市新政，进一步便利特专科技公司及生物科技公司申请上市，并允许这些公司可以 选择以保密形式提交上市申请。 港交所上市主管伍洁镟表示，港交所始终将吸 ...